Congjun Xu
机构:Hainan University, Hainan Medical University · ORCID:0000-0003-1603-7142
发表论文 34 篇 · 总被引 565 次 · h-index 13
代表论文
- Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy (2022 · Biomaterials · 被引 58)
- Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer (2021 · Journal of Medicinal Chemistry · 被引 57)
- Identification of a natural PLA2 inhibitor from the marine fungus Aspergillus sp. c1 for MAFLD treatment that suppressed lipotoxicity by inhibiting the IRE-1α/XBP-1s axis and JNK signaling (2023 · Acta Pharmaceutica Sinica B · 被引 21)
- Development of a Highly Selective Ferroptosis Inducer Targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as Electrophilic Warhead (2025 · Journal of Medicinal Chemistry · 被引 20)
- A GSH-responsive oxidative stress nanoamplifier for self-augmented chemo/chemodynamic therapy to reverse cisplatin resistance (2024 · Acta Biomaterialia · 被引 18)
- A facile method for anti-cancer drug encapsulation into polymersomes with a core-satellite structure (2022 · Drug Delivery · 被引 16)